TURNING PT THER (TPTX)
(Delayed Data from NSDQ)
$32.54 USD
-1.16 (-3.44%)
Updated May 3, 2019 04:00 PM ET
After-Market: $32.56 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TPTX 32.54 -1.16(-3.44%)
Will TPTX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TPTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TPTX
Is IQ Chaikin U.S. Small Cap ETF (CSML) a Strong ETF Right Now?
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar?
TPTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bristol-Myers (BMY) Q2 Earnings, Sales Beat on Eliquis, Opdivo
Bristol-Myers (BMY) to Post Q2 Earnings: What is in the Cards?
Bristol Myers (BMY) Up 20.4% YTD: Will the Momentum Continue?